On Monday, Pyxis Oncology Inc (NASDAQ: PYXS) opened lower -4.50% from the last session, before settling in for the closing price of $1.11. Price fluctuations for PYXS have ranged from $0.83 to $5.55 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -74.92% over the last five years. Company’s average yearly earnings per share was noted 1.43% at the time writing. With a float of $48.09 million, this company’s outstanding shares have now reached $62.15 million.
Pyxis Oncology Inc (PYXS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Pyxis Oncology Inc is 22.76%, while institutional ownership is 38.03%. The most recent insider transaction that took place on Apr 21 ’25, was worth 14,362. Before that another transaction happened on Apr 17 ’25, when Company’s Director proposed sale 200 for $0.97, making the entire transaction worth $194.
Pyxis Oncology Inc (PYXS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.26 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.33) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.43% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.25% during the next five years compared to -74.92% drop over the previous five years of trading.
Pyxis Oncology Inc (NASDAQ: PYXS) Trading Performance Indicators
Check out the current performance indicators for Pyxis Oncology Inc (PYXS). In the past quarter, the stock posted a quick ratio of 4.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.18 in one year’s time.
Technical Analysis of Pyxis Oncology Inc (PYXS)
Analysing the last 5-days average volume posted by the [Pyxis Oncology Inc, PYXS], we can find that recorded value of 2.1 million was better than the volume posted last year of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 1.66%.
During the past 100 days, Pyxis Oncology Inc’s (PYXS) raw stochastic average was set at 1.97%, which indicates a significant increase from 0.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2929 in the past 14 days, which was higher than the 0.2757 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.7467, while its 200-day Moving Average is $1.9939. Now, the first resistance to watch is $1.1267. This is followed by the second major resistance level at $1.1933. The third major resistance level sits at $1.2367. If the price goes on to break the first support level at $1.0167, it is likely to go to the next support level at $0.9733. Now, if the price goes above the second support level, the third support stands at $0.9067.
Pyxis Oncology Inc (NASDAQ: PYXS) Key Stats
There are currently 62,264K shares outstanding in the company with a market cap of 66.00 million. Presently, the company’s annual sales total 16,150 K according to its annual income of -77,330 K. Last quarter, the company’s sales amounted to 2,820 K and its income totaled -18,350 K.
